Found: 49
Select item for more details and to access through your institution.
Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 7, p. 980, doi. 10.1111/apt.18215
- By:
- Publication type:
- Article
Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants.
- Published in:
- BMC Biology, 2018, v. 16, n. 1, p. 1, doi. 10.1186/s12915-018-0530-7
- By:
- Publication type:
- Article
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 2, p. 501, doi. 10.1172/JCI73722
- By:
- Publication type:
- Article
Animal models in nonalcoholic steatohepatitis research: utility and clinical translation.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2415, doi. 10.3390/jcm10112415
- By:
- Publication type:
- Article
How effective are experienced hepatologists at staging fibrosis using non‐invasive fibrosis tests in patients with metabolic dysfunction‐associated steatotic liver disease?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 267, doi. 10.1111/apt.18061
- By:
- Publication type:
- Article
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 51, doi. 10.1111/apt.17734
- By:
- Publication type:
- Article
Review article: The need for more efficient and patient‐oriented drug development pathways in NASH—setting the scene for platform trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 9, p. 948, doi. 10.1111/apt.17456
- By:
- Publication type:
- Article
Letter: non‐invasive prediction models to exclude cirrhosis in NAFLD—not everyone fits the mould. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 182, doi. 10.1111/apt.16972
- By:
- Publication type:
- Article
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 11, p. 1441, doi. 10.1111/apt.16874
- By:
- Publication type:
- Article
Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0300362
- By:
- Publication type:
- Article
Multigenerational epigenetic adaptation of the hepatic wound-healing response.
- Published in:
- Nature Medicine, 2012, v. 18, n. 10, p. 1592, doi. 10.1038/nm1012-1592c
- By:
- Publication type:
- Article
Multigenerational epigenetic adaptation of the hepatic wound-healing response.
- Published in:
- Nature Medicine, 2012, v. 18, n. 9, p. 1369, doi. 10.1038/nm.2893
- By:
- Publication type:
- Article
How to Diagnose Nonalcoholic Fatty Liver Disease.
- Published in:
- Digestive Diseases, 2016, v. 34, p. 19, doi. 10.1159/000447277
- By:
- Publication type:
- Article
Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study.
- Published in:
- Hepatology Research, 2018, v. 48, n. 1, p. 69, doi. 10.1111/hepr.12904
- By:
- Publication type:
- Article
Mutations in <i>Mll2</i>, an H3K4 Methyltransferase, Result in Insulin Resistance and Impaired Glucose Tolerance in Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0061870
- By:
- Publication type:
- Article
Clinicians' Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 10, p. 2707, doi. 10.3390/jcm11102707
- By:
- Publication type:
- Article
Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2910, doi. 10.3390/jcm10132910
- By:
- Publication type:
- Article
Handling Overlapping Asymmetric Data Sets—A Twice Penalized P-Spline Approach.
- Published in:
- Mathematics (2227-7390), 2024, v. 12, n. 5, p. 777, doi. 10.3390/math12050777
- By:
- Publication type:
- Article
A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1412, doi. 10.3390/cancers13061412
- By:
- Publication type:
- Article
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study.
- Published in:
- Patient, 2021, v. 14, n. 5, p. 533, doi. 10.1007/s40271-020-00485-w
- By:
- Publication type:
- Article
Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review.
- Published in:
- Liver International, 2021, v. 41, n. 2, p. 261, doi. 10.1111/liv.14669
- By:
- Publication type:
- Article
The role of intestinal microbiota in murine models of acetaminophen-induced hepatotoxicity.
- Published in:
- Liver International, 2015, v. 35, n. 3, p. 764, doi. 10.1111/liv.12689
- By:
- Publication type:
- Article
Multi-excitation fluorescence spectroscopy for analysis of non-alcoholic fatty liver disease.
- Published in:
- Lasers in Surgery & Medicine, 2011, v. 43, n. 5, p. 392, doi. 10.1002/lsm.21064
- By:
- Publication type:
- Article
Pharmacological testing of therapeutics using normothermic machine perfusion: A pilot study of 2,4‐dinitrophenol delivery to steatotic human livers.
- Published in:
- Artificial Organs, 2022, v. 46, n. 11, p. 2201, doi. 10.1111/aor.14309
- By:
- Publication type:
- Article
Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 9, p. 1, doi. 10.1371/journal.pone.0238717
- By:
- Publication type:
- Article
Genetics of alcoholic liver disease and non-alcoholic steatohepatitis.
- Published in:
- Clinical Medicine, 2018, v. 18, p. s54, doi. 10.7861/clinmedicine.18-2-s54
- By:
- Publication type:
- Article
An overview of the genetics, mechanisms and management of NAFLD and ALD.
- Published in:
- Clinical Medicine, 2015, v. 15, p. s77, doi. 10.7861/clinmedicine.15-6-s77
- By:
- Publication type:
- Article
The importance of fatty liver disease in clinical practice.
- Published in:
- Proceedings of the Nutrition Society, 2010, v. 69, n. 4, p. 518, doi. 10.1017/S0029665110001916
- By:
- Publication type:
- Article
The pathway to better primary care for chronic liver disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Quantifying hepatic steatosis - more than meets the eye.
- Published in:
- Histopathology, 2012, v. 60, n. 6, p. 971, doi. 10.1111/j.1365-2559.2012.04193.x
- By:
- Publication type:
- Article
Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey.
- Published in:
- Pragmatic & Observational Research, 2023, v. 14, p. 13, doi. 10.2147/POR.S392320
- By:
- Publication type:
- Article
Cellular senescence drives age-dependent hepatic steatosis.
- Published in:
- Nature Communications, 2017, v. 8, n. 6, p. 15691, doi. 10.1038/ncomms15691
- By:
- Publication type:
- Article
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.
- Published in:
- Nature Communications, 2014, v. 5, n. 6, p. 4309, doi. 10.1038/ncomms5309
- By:
- Publication type:
- Article
Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition.
- Published in:
- Nature Communications, 2013, v. 4, n. 11, p. 2816, doi. 10.1038/ncomms3816
- By:
- Publication type:
- Article
A molecular signature for the metabolic syndrome by urine metabolomics.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01349-9
- By:
- Publication type:
- Article
Thrombin and factor Xa link the coagulation system with liver fibrosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00589-5
- By:
- Publication type:
- Article
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Biomedicines, 2021, v. 9, n. 12, p. 1920, doi. 10.3390/biomedicines9121920
- By:
- Publication type:
- Article
Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.
- Published in:
- International Journal of Experimental Pathology, 2006, v. 87, n. 1, p. 1, doi. 10.1111/j.0959-9673.2006.00465.x
- By:
- Publication type:
- Article
Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial.
- Published in:
- Clinical Science, 2015, v. 129, n. 12, p. 1097, doi. 10.1042/CS20150308
- By:
- Publication type:
- Article
Editorial: collagen proportionate area as a prognostic indicator in NAFLD.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Predictors of advanced fibrosis in non‐cirrhotic non‐alcoholic fatty liver disease in Germany.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 10, p. 1109, doi. 10.1111/apt.14976
- By:
- Publication type:
- Article
Editorial: hepatocellular carcinoma in non‐cirrhotic NASH—a troubling reality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 9, p. 1021, doi. 10.1111/apt.14982
- By:
- Publication type:
- Article
Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 616, p. 1, doi. 10.1126/scitranslmed.abe8939
- By:
- Publication type:
- Article
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0175717
- By:
- Publication type:
- Article